|
|
 Previous Article | Table of Contents | Next Article 
Monitoring of tumor cell purging after highly efficient immunomagnetic
selection of CD34 cells from leukapheresis products in breast cancer
patients: comparison of immunocytochemical tumor cell staining and reverse
transcriptase-polymerase chain reaction
MY Mapara, IJ Korner, M Hildebrandt, R Bargou, D Krahl, P Reichardt and B Dorken
Department of Internal Medicine (Medical Oncology and Tumorimmunology),
Humboldt University, Virchow Klinikum-Robert Rossle Klinik, Berlin,
Germany.
We studied the efficiency of indirect tumor cell purging via enrichment of
CD34+ hematopoietic progenitor cells from leukapheresis products (LP) in
breast cancer patients based on immunomagnetic selection of CD34+ cells.
Detection of tumor cells was made by immunocytochemical staining. In
addition, we evaluated the capacity of cytokeratin 19 (CK19)- and a novel
epidermal growth factor receptor (EGF-R)-specific reverse
transcriptase-polymerase chain reaction (RT-PCR) for monitoring tumor cell
depletion. LP from 13 breast cancer patients were analyzed. Twenty-three
CD34 selection procedures were performed. A median of 1.4 x 10(10) total
nucleated cells ([TNC] range, 0.88 to 3.5 x 10(10)) with a median CD34
purity of 2.5% (range, 0.4% to 6.3%) were entered into the selection
procedure. Immunomagnetic CD34 enrichment resulted in a median purity of
83.3% (range, 45% to 95.4%) and a median recovery of 73.2% (range, 22% to
95%). Retransfusion of CD34-selected cells after high-dose chemotherapy
resulted in a rapid and sustained hematologic recovery, reaching an
absolute neutrophil count of 500/microL at day +10 and platelet count of
20,000/microL at day +11. Tumor cell depletion was quantified by
immunocytochemical detection of CK19- positive cells. By this method, a
median tumor cell depletion of 1.9 log (range, 0.7 to > 3 log) could be
demonstrated. Immunocytochemical detection of tumor cells was more
sensitive than RT-PCR, yielding positive results in 81% of LP (17 to 21)
versus 58% positive LP (10 of 17). However, EGF-R-based RT-PCR was much
more sensitive than CK19- based RT-PCR (10 of 17 v 1 of 17). Despite highly
efficient CD34 selection, tumor cells were still detectable after CD34
enrichment using immunocytochemistry and EGF-R-specific RT-PCR. Thus, this
novel EGF-R-specific RT-PCR appears to be of value as an additional method
to detect contaminating breast cancer cells within LP.
Volume 89,
Issue 1,
pp. 337-344,
01/01/1997
Copyright © 1997 by The American Society of Hematology
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
J. C. Hu, M. J. Booth, G. Tripuraneni, D. Davies, S. A.A. Zaidi, M. Tamburo de Bella, M. J. Slade, S. B. Marley, M. Y.A. Gordon, R. S. Coffin, et al.
A Novel HSV-1 Virus, JS1/34.5-/47-, Purges Contaminating Breast Cancer Cells From Bone Marrow.
Clin. Cancer Res.,
November 15, 2006;
12(22):
6853 - 6862.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Fujiwara, K. Higuchi, T. Takashima, M. Hamaguchi, T. Hayakawa, K. Tominaga, T. Watanabe, N. Oshitani, Y. Shimada, and T. Arakawa
Roles of epidermal growth factor and Na+/H+ exchanger-1 in esophageal epithelial defense against acid-induced injury
Am J Physiol Gastrointest Liver Physiol,
April 1, 2006;
290(4):
G665 - G673.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Lillo, M. Ramirez, A. Alvarez, S. Santos, J. Garcia-Castro, J. Fernandez de Velasco, M. J. Aviles, A. Gomez-Pineda, J. L. Diez, A. Balas, et al.
Efficient and Nontoxic Adenoviral Purging Method for Autologous Transplantation in Breast Cancer Patients
Cancer Res.,
September 1, 2002;
62(17):
5013 - 5018.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. J. Bosma, B. Weigelt, A. C. Lambrechts, O. J. H. M. Verhagen, R. Pruntel, A. A. M. Hart, S. Rodenhuis, and L. J. v.'t Veer
Detection of Circulating Breast Tumor Cells by Differential Expression of Marker Genes
Clin. Cancer Res.,
June 1, 2002;
8(6):
1871 - 1877.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Richter, M. Hayden-Ledbetter, M. Irgang, J. A. Ledbetter, J. Westermann, I. Korner, K. Daemen, E. A. Clark, A. Aicher, and A. Pezzutto
Tumor Necrosis Factor-alpha Regulates the Expression of Inducible Costimulator Receptor Ligand on CD34+ Progenitor Cells during Differentiation into Antigen Presenting Cells
J. Biol. Chem.,
November 30, 2001;
276(49):
45686 - 45693.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. C. Redmond, J. H. Wang, K. K. Austin, N. Relihan, G. McGreal, W. O. Kirwan, D. Richardson, J. Kelly, H. P. Redmond, S. Braun, et al.
Is Immunohistochemical Analysis an Appropriate Diagnostic Technique for Bone Marrow Micrometastases?
J. Clin. Oncol.,
August 1, 2001;
19(15):
3589 - 3592.
[Full Text]
|
|
|
|
|
|
|
M. Mohr, F. Dalmis, E. Hilgenfeld, E. Oelmann, M. Zühlsdorf, K. Kratz-Albers, A. Nolte, C. Schmitmann, D. Önaldi-Mohr, U. Cassens, et al.
Simultaneous Immunomagnetic CD34+ Cell Selection and B-Cell Depletion in Peripheral Blood Progenitor Cell Samples of Patients Suffering from B-Cell Non-Hodgkin's Lymphoma
Clin. Cancer Res.,
January 1, 2001;
7(1):
51 - 57.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
C. P. Schröder, B.-J. Kroesen, L. F. M. H. de Leij, and E. G. E. de Vries
Purging of Epithelial Tumor Cells from Peripheral Blood Stem Cells by Means of the Bispecific Antibody BIS-1
Clin. Cancer Res.,
June 1, 2000;
6(6):
2521 - 2527.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
Antonella De Luca, S. Pignata, A. Casamassimi, A. D’Antonio, C. Gridelli, A. Rossi, F. Cremona, V. Parisi, Andrea De Matteis, and N. Normanno
Detection of Circulating Tumor Cells in Carcinoma Patients by a Novel Epidermal Growth Factor Receptor Reverse Transcription-PCR Assay
Clin. Cancer Res.,
April 1, 2000;
6(4):
1439 - 1444.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
K. Pantel, R. J. Cote, and O. Fodstad
Detection and Clinical Importance of Micrometastatic Disease
J Natl Cancer Inst,
July 7, 1999;
91(13):
1113 - 1124.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Zach, H. Kasparu, O. Krieger, W. Hehenwarter, M. Girschikofsky, and D. Lutz
Detection of Circulating Mammary Carcinoma Cells in the Peripheral Blood of Breast Cancer Patients Via a Nested Reverse Transcriptase Polymerase Chain Reaction Assay for Mammaglobin mRNA
J. Clin. Oncol.,
July 1, 1999;
17(7):
2015 - 2015.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Mohr, E. Hilgenfeld, T. Fietz, B. Hoppe, M. Koenigsmann, M. Hoffmann, W. U. Knauf, U. Cassens, W. Sibrowski, J. Kienast, et al.
Efficacy and Safety of Simultaneous Immunomagnetic CD34+ Cell Selection and Breast Cancer Cell Purging in Peripheral Blood Progenitor Cell Samples Used for Hematopoietic Rescue after High-Dose Therapy
Clin. Cancer Res.,
May 1, 1999;
5(5):
1035 - 1040.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Spyridonidis, W. Bernhardt, D. Behringer, G. Kohler, M. Azemar, A. Pflug, and R. Henschler
Proliferation and Survival of Mammary Carcinoma Cells Are Influenced by Culture Conditions Used for Ex Vivo Expansion of CD34+ Blood Progenitor Cells
Blood,
January 15, 1999;
93(2):
746 - 755.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Tarella, F. Zallio, D. Caracciolo, C. Cherasco, P. Bondesan, P. Gavarotti, P. Corradini, V. Tassi, and A. Pileri
Hemopoietic Progenitor Cell Mobilization and Harvest Following an Intensive Chemotherapy Debulking in Indolent Lymphoma Patients
Stem Cells,
January 1, 1999;
17(1):
55 - 61.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
B. Panzenbock, P. Bartunek, M. Y. Mapara, and M. Zenke
Growth and Differentiation of Human Stem Cell Factor/Erythropoietin-Dependent Erythroid Progenitor Cells In Vitro
Blood,
November 15, 1998;
92(10):
3658 - 3668.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Rambaldi, G. Borleri, G. Dotti, P. Bellavita, R. Amaru, A. Biondi, and T. Barbui
Innovative Two-Step Negative Selection of Granulocyte Colony-Stimulating Factor-Mobilized Circulating Progenitor Cells: Adequacy for Autologous and Allogeneic Transplantation
Blood,
March 15, 1998;
91(6):
2189 - 2196.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Spyridonidis, M. Schmidt, W. Bernhardt, A. Papadimitriou, M. Azemar, W. Wels, B. Groner, and R. Henschler
Purging of Mammary Carcinoma Cells During Ex Vivo Culture of CD34+ Hematopoietic Progenitor Cells With Recombinant Immunotoxins
Blood,
March 1, 1998;
91(5):
1820 - 1827.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
